Accretion Nutraveda came to market through an SME IPO that opened on 28 January 2026 and closed on 30 January 2026, and the shares listed on 4 February 2026 on BSE SME. The price band was ₹122 to ₹129 per share and one lot was 1000 shares, so the minimum application was ₹1,29,000. The issue size was ₹24.77 crore. The whole issue was fresh shares, so the money raised went to the company.
Kfin Technologies Ltd was the registrar to the issue, and Sobhagya Capital Options Pvt.Ltd was the lead manager.
As of 30 January 2026.
| Day |
|---|
| 1 |
| 2 |
| 3 |
| 4 |
Incorporated in the year 2021, Accretion Nutraveda is engaged in the manfacturing of Ayurvedic and nutraceutical products in different dosage forms, which include tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels. The company is a Contract Development and Manufacturing Organization (CDMO) that caters to both local and international markets, including Sri Lanka, Singapore, and USA.
It provides products that incorporate the wisdom of Ayurvedic science, along with the latest nutraceutical technology, to alleviate conditions such as liver care, women’s health, boneness and joint care, brain support, and respiratory health. Business verticals: Domestic Sales & Merchant Exports (Loan Licence Basis) - contributing 96.62% to total revenues in FY 2024-25. Direct Exports– Contributing 38%, with a constant rise in It has a manufacturing plant in Gujarat which occupies around 10,763 sq. ft.
and is well-equipped with latest infrastructure like 13 air handling units, processing areas, and quality control equipment. The plant is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified along with FSSAI license.
As described in the offer document.
| Metric | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Mr. Vivek Ashok Kumar Patel. Promoter holding 100% before the issue and 73.48% after.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Accretion Nutraveda IPO was a ₹24.77 crore book-built issue, made up entirely of a fresh issue. It was priced at ₹122–₹129 per share with a lot size of 1,000 shares; the minimum retail application was 2,000 shares (₹2,58,000). The IPO was open from January 28 to January 30, 2026 and was subscribed 1.91x. Shares listed on BSE SME on February 4, 2026 at ₹191, a 48.1% premium to the issue price of ₹129. Kfin Technologies Ltd. is the registrar.
Sobhagya Capital Options Pvt. Ltd. is the book running lead manager.
The price band of Accretion Nutraveda IPO is ₹122 to ₹129 per share.
The lot size of Accretion Nutraveda IPO is 1000 shares.
The minimum investment for Accretion Nutraveda IPO is approximately ₹2,58,000 based on the upper price band.
The allotment date of Accretion Nutraveda IPO is Feb 2, 2026.
You can check Accretion Nutraveda IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Accretion Nutraveda IPO allotment status on Rupix for quick and easy access.
₹122 to ₹129 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 1000 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,29,000. After listing, SME shares also trade in lots rather than one share at a time.
₹1,29,000, for one lot of 1000 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 28 January 2026 and closed on 30 January 2026.
The basis of allotment was published on 2 February 2026 by Kfin Technologies Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 4 February 2026 on BSE SME.
The issue size was ₹24.77 crore. The fresh issue was 19,20,000 shares (aggregating up to ₹24.77 crore).